Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93
Published January 22, 2025 · Recall initiated: December 23, 2024
Summary
FDA records drug Class II recall D-0204-2025, published January 22, 2025 and initiated December 23, 2024. Recalling firm: Viatris Inc; Status: Terminated; Reported quantity: 6,605/30 count bottles; Lot: Lot# 8182298, Exp 10/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email if CARDURA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CARDURA
- Manufacturer
- Viatris Inc
- Distributor
- USA nationwide.
- UPC
- 0358151078936
- Lot
- Lot# 8182298, Exp 10/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by ViatrisJanuary 22, 2025
- FDAOrgain 30g Plant Protein, Complete Protein Powder, 6g Prebiotic +Fiber, 9g EAAS+BCAAs, 1gSugar, ChocolateJanuary 22, 2025
- FDAglipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by:January 22, 2025
- FDADELI FRESH VEGETABLE TRAY MED, 4 lb., packaged in a plastic container with a plastic lid, UPC 11110-99274January 22, 2025
- FDAClobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, AmnealJanuary 22, 2025
- FDASMALL VEGGIE PLATTER, 32 oz., packaged in a plastic container with a plastic lid, UPC 41573-26809January 22, 2025
Questions about this recall
Was Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93 recalled?
Yes. FDA published recall D-0204-2025 on January 22, 2025. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CARDURA. UPC: 0358151078936.